R
Richard J. Lobb
Researcher at QIMR Berghofer Medical Research Institute
Publications - 25
Citations - 2536
Richard J. Lobb is an academic researcher from QIMR Berghofer Medical Research Institute. The author has contributed to research in topics: Microvesicles & Cancer. The author has an hindex of 13, co-authored 20 publications receiving 1565 citations. Previous affiliations of Richard J. Lobb include University of Queensland.
Papers
More filters
Journal ArticleDOI
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Richard J. Lobb,Melanie Becker,Shu Wen Wen,Christina S. F. Wong,Adrian P. Wiegmans,Antoine Leimgruber,Andreas Möller +6 more
TL;DR: It is shown that concentration of cell culture conditioned media using ultrafiltration devices results in increased vesicle isolation when compared to traditional ultracentrifugation protocols, and it is demonstrated that size exclusion isolation is comparable to density gradient purification of exosomes.
Journal ArticleDOI
The evolving translational potential of small extracellular vesicles in cancer.
Andreas Möller,Richard J. Lobb +1 more
TL;DR: This Review highlights the progress the cancer sEV field has made in the areas of biomarker discovery and validation as well as sEV-based therapeutics, highlights the challenges the authors are facing and identifies gaps in knowledge, which currently prevent the full potential of sEVs in cancer diagnostic and therapy.
Journal ArticleDOI
The Biodistribution and Immune Suppressive Effects of Breast Cancer–Derived Exosomes
Shu Wen Wen,Jaclyn Sceneay,Luize G. Lima,Christina S. F. Wong,Melanie Becker,Sophie Krumeich,Richard J. Lobb,Vanessa Castillo,Ke Ni Wong,Sarah Ellis,Belinda S. Parker,Andreas Möller,Andreas Möller +12 more
TL;DR: It is determined that breast cancer exosomes directly suppressed T-cell proliferation and inhibited NK cell cytotoxicity, and hence likely suppressed the anticancer immune response in premetastatic organs.
Journal ArticleDOI
Exosomes: Key mediators of metastasis and pre-metastatic niche formation.
TL;DR: The recent findings that implicate this non-canonical signalling within the tumour as a critical driver of metastatic disease progression are summarized, and how understanding the molecular mechanisms involved in exosome-mediated metastasis is of great value for the development of new therapeutic strategies to prevent cancer progression is discussed.
Journal ArticleDOI
Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling.
Sunyoung Ham,Sunyoung Ham,Luize G. Lima,Edna Pei Zhi Chai,Edna Pei Zhi Chai,Alexandra F. Müller,Alexandra F. Müller,Richard J. Lobb,Richard J. Lobb,Sophie Krumeich,Shu Wen Wen,Adrian P. Wiegmans,Andreas Möller,Andreas Möller,Andreas Möller +14 more
TL;DR: It is demonstrated that breast cancer-derived exosomes are capable of inducing IL-6 secretion and a pro-survival phenotype in macrophages, partially via gp130/STAT3 signaling.